← Back to search

Protein Structures and Oligomeric States

Enter a protein name, UniProt accession or PDB ID. Name searches ask you to confirm the protein identity before related structures are queried.

Current Protein Identity：C7S9T0 New Search
5PDB entries
13Biological assembly
13chain/assembly records
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
7S5S CTX-M-15 WT in complex with BLIP WT Deposited 2021-09-11 Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count
Chain A 50–311（262 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；298 K；20% w/v PEG3350, 0.2 M NaF, 0.1 M Bis-Tris-propane pH 6.5
Resolution 1.40 Å R-free 0.166
7U48 Clavulanic acid-CTX-M-15 Deposited 2022-02-28 Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain A 21–311（291 aa）
Mutation：A25P, Q26L GOL GLYCEROL × 2 LBX (E)-5-hydroxy-3-oxo-N-(3-oxopropylidene)-L-norvaline × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 1.67 Å R-free 0.285
7U48 Clavulanic acid-CTX-M-15 Deposited 2022-02-28 Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain B 21–311（291 aa）
Mutation：A25P, Q26L LBX (E)-5-hydroxy-3-oxo-N-(3-oxopropylidene)-L-norvaline × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 1.67 Å R-free 0.285
7U48 Clavulanic acid-CTX-M-15 Deposited 2022-02-28 Assembly 3 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain C 21–311（291 aa）
Mutation：A25P, Q26L LBX (E)-5-hydroxy-3-oxo-N-(3-oxopropylidene)-L-norvaline × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 1.67 Å R-free 0.285
7U49 DFC-CTX-M-15 Deposited 2022-02-28 Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain A 21–311（291 aa）
Not recorded LD0 (2R,4S,5R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-(sulfanylmethyl)-1,3-thiazinane-4-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 1.72 Å R-free 0.323
7U49 DFC-CTX-M-15 Deposited 2022-02-28 Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain B 21–311（291 aa）
Not recorded LD0 (2R,4S,5R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-(sulfanylmethyl)-1,3-thiazinane-4-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 1.72 Å R-free 0.323
7U49 DFC-CTX-M-15 Deposited 2022-02-28 Assembly 3 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain C 21–311（291 aa）
Not recorded LD0 (2R,4S,5R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-(sulfanylmethyl)-1,3-thiazinane-4-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 1.72 Å R-free 0.323
7U4B Ampicillin-CTX-M-15 Deposited 2022-02-28 Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain A 21–310（290 aa）
Mutation：A48P, Q49L NW3 (2S,4S)-2-[(1S)-1-{[(2S)-2-amino-2-phenylacetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 1.92 Å R-free 0.270
7U4B Ampicillin-CTX-M-15 Deposited 2022-02-28 Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain B 21–310（290 aa）
Mutation：A48P, Q49L NW3 (2S,4S)-2-[(1S)-1-{[(2S)-2-amino-2-phenylacetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 1.92 Å R-free 0.270
7U4B Ampicillin-CTX-M-15 Deposited 2022-02-28 Assembly 3 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain C 21–310（290 aa）
Mutation：A48P, Q49L NW3 (2S,4S)-2-[(1S)-1-{[(2S)-2-amino-2-phenylacetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 1.92 Å R-free 0.270
7U57 apo-CTX-M-15 Deposited 2022-03-01 Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain A 21–311（291 aa）
Mutation：A25P, Q26L SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 2.37 Å R-free 0.327
7U57 apo-CTX-M-15 Deposited 2022-03-01 Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain B 21–311（291 aa）
Mutation：A25P, Q26L SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 2.37 Å R-free 0.327
7U57 apo-CTX-M-15 Deposited 2022-03-01 Assembly 3 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count
Chain C 21–311（291 aa）
Mutation：A25P, Q26L SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.8；293 K；300 mM Ammonium sulfate, 30% PEG 4000
Resolution 2.37 Å R-free 0.327

This page presents structural evidence recorded in PDB/mmCIF.“No recorded non-water small molecule” does not prove that the experimental sample was ligand-free; experimental conditions belong to the PDB experiment, while ligands and copy counts are shown for each biological assembly.